13C-PT630

Ref. 3D-PP47011

Informations sur le produit

• Nom: 13C-PT630
• Synonymes: 13Cys-PT630

Description

Peptide 13C-PT630 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using 13C-PT630 include the following: Ming-Hui Fan1, Qiang Zhu2, Hui-Hua Li1, Hyun-Jeong Ra3, Sonali Majumdar4, Dexter L. Gulick1, Jacob A. Jerome1, Daniel H. Madsen5, Melpo Christofidou WW Bachovchin, C Feghali-Bostwick, E Pure - 2015 - researchgate.nethttps://www.researchgate.net/profile/Rajrupa-Majumdar/publication/286643393_Fibroblast_Activation_Protein_FAP_Accelerates_Collagen_Degradation_and_Clearance_from_Lung_in_Mice/links/57a7dbeb08ae3f4529393057/Fibroblast-Activation-Protein-FAP-Accelerates-Collagen-Degradation-and-Clearance-from-Lung-in-Mice.pdf Stromal Gene Signatures as Source of Targets for Drug-Repositioning and Prognostic Biomarkers in Prostate Cancer V Doldi - 2020 - search.proquest.comhttps://search.proquest.com/openview/776abcf67baabd4b186f8aa7fe471442/1?pq-origsite=gscholar&cbl=2026366&diss=y Dipeptidyl Peptidase Inhibition Decreases Osteosarcoma Tumor Formation by Targeting Stromal Elements and Immune Stimulation SY Kim , M Guimond, HJ Meany, S Strahan - Journal of , 2006 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2006/11000/dipeptidyl_peptidase_inhibition_decreases.179.aspx Preclinical assessment of fibroblast activation protein as a target for antitumor therapy SW Hayward - Future Oncology, 2010 - Future Medicinehttps://www.futuremedicine.com/doi/abs/10.2217/fon.10.8 Fibroblast activation protein: A potential therapeutic target in cancer R Liu, H Li, L Liu, J Yu, X Ren - Cancer biology & therapy, 2012 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/cbt.13.3.18696 Targeting fibroblast activation protein in cancer-Prospects and caveats P Busek , R Mateu, M Zubal, L Kotackova - Biosci (Landmark Edhttps://www.researchgate.net/profile/Aleksi-Sedo/publication/325500629_Targeting_Fibroblast_activation_protein_in_cancer_-_Prospects_and_caveats/links/64d3aef5c80b930269fb6409/Targeting-Fibroblast-activation-protein-in-cancer-Prospects-and-caveats.pdf Review of cancer-associated fibroblasts and therapies that interfere with their activity N Takebe, P Ivy, W Timmer, N Khan - Tumor , 2013 - researchgate.nethttps://www.researchgate.net/profile/Pamela-Harris-7/publication/258879070_Cancer-associated_Fibroblasts_and_Therapies_That_Interfere_with_Their_Activity/links/02e7e5294e59555443000000/Cancer-associated-Fibroblasts-and-Therapies-That-Interfere-with-Their-Activity.pdf Immune Cytolysis Induces HMGB1 Release Through a Partially Caspase Dependent Apoptotic Pathway N Ito, RA Demarco, RB Mailliard , J Han - Journal of , 2006 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2006/11000/Immune_Cytolysis_Induces_HMGB1_Release_Through_a.178.aspx Fibroblast activation protein in remodeling tissues M Jacob, L Chang, E Pure - Current molecular medicine, 2012 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmm/2012/00000012/00000010/art00002 Activation of fibroblasts in cancer stroma K Rasanen, A Vaheri - Experimental cell research, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S001448271000203X Immunoediting of Cancers may Lead to Epithelial to Mesenchymal Transition JM Reiman, MD Behrens, ML Disis - Journal of , 2006 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2006/11000/Immunoediting_of_Cancers_may_Lead_to_Epithelial_to.180.aspx Pituitary Tumor Transforming Gene 1 is Expressed in Kupffer Cells, Activated T Lymphocytes and a Proportion of Primary Liver Cancer Cells F Grizzi , S Musardo, B Franceschini - Journal of , 2006 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2006/11000/Pituitary_Tumor_Transforming_Gene_1_is_Expressed.177.aspx The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer E Pure - Expert Opinion on Therapeutic Targets, 2009 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1517/14728220903103841 Targeting Fibroblasts in Fibrosis and Cancer AMRH Mostafa, R Bansal, J Prakash - 2020 - books.rsc.orghttps://books.rsc.org/books/edited-volume/824/chapter/565242 Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice AM Santos, J Jung, N Aziz , JL Kissil - The Journal of clinical , 2009 - Am Soc Clin Investighttps://www.jci.org/articles/view/38988 Investigation of the biological function of fibroblast activation protein and its potential as a therapeutic target in cancer and diabetes AL Coppage - 2015 - search.proquest.comhttps://search.proquest.com/openview/5b0bf4450b38d799a268bcadef876450/1?pq-origsite=gscholar&cbl=18750

• Marque: Biosynth